Comparison of Kinetic Modeling Methods for the In Vivo Quantification of 5-HT1A Receptors Using WAY 100635
暂无分享,去创建一个
Ramin V. Parsey | Osama Mawlawi | Mark Slifstein | Marc Laruelle | Dah-Ren Hwang | Anissa Abi-Dargham | Ronald L. Van Heertum | Ann K. Shinn | R. Parsey | O. Mawlawi | N. Guo | D. Hwang | M. Laruelle | A. Abi-Dargham | M. Slifstein | J. Mann | N. Simpson | J. John Mann | Norman Simpson | Ningning Guo | R. Heertum
[1] Christer Halldin,et al. Measurement of Striatal and Extrastriatal Dopamine D1 Receptor Binding Potential With [11C]NNC 112 in Humans: Validation and Reproducibility , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] S Grootoonk,et al. Performance Evaluation of the Positron Scanner ECAT EXACT , 1992, Journal of computer assisted tomography.
[3] D. Hwang,et al. An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635. , 1999, Nuclear medicine and biology.
[4] H. Akaike. A new look at the statistical model identification , 1974 .
[5] J. Mazziotta,et al. Rapid Automated Algorithm for Aligning and Reslicing PET Images , 1992, Journal of computer assisted tomography.
[6] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] G. Gessa,et al. Brain dialysis and dopamine: does the extracellular concentration of dopamine reflect synaptic release? , 1990, European journal of pharmacology.
[8] I A Cliffe,et al. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. , 1995, European journal of pharmacology.
[9] M. Hamon,et al. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. , 1995, European journal of pharmacology.
[10] Allan L. Reiss,et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome , 1997, Psychiatry Research: Neuroimaging.
[11] T Sandor,et al. An interactive procedure for extracting features of the brain from magnetic resonance images: The lobes , 1997, Human brain mapping.
[12] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.